Little Green Pharma Ltd (ASX:LGP)

Little Green Pharma Income Statement

Financials in millions AUD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Revenue	42.43	36.82	25.63	19.86	14.04
Other Revenue	-	0.02	1.49	-	-
Revenue	42.43	36.84	27.12	19.86	14.04
Revenue Growth (YoY)	15.16%	35.85%	36.55%	41.45%	100.47%
Cost of Revenue	12.28	11.9	6.22	6.06	6.69
Gross Profit	30.14	24.94	20.9	13.8	7.35
Selling, General & Admin	22.94	22.04	22.37	19.52	25.66
Research & Development	0.05	0.29	0.58	1.47	4.06
Other Operating Expenses	0.01	0.01	0.07	-	-
Operating Expenses	28.02	28.47	28.35	20.98	29.72
Operating Income	2.12	-3.53	-7.45	-7.18	-22.37
Interest Expense	-0.44	-0.29	-0.58	-0.93	-0.72
Interest & Investment Income	0.07	0.02	0.17	0.05	0.04
Currency Exchange Gain (Loss)	0.04	-0.05	0.01	-0.56	-1.35
Other Non Operating Income (Expenses)	-0.11	-0.09	-0.06	0.06	0.33
EBT Excluding Unusual Items	1.68	-3.95	-7.91	-8.56	-24.07
Asset Writedown	-3.3	-0.85	-0.24	-	-
Pretax Income	-1.54	-4.79	-8.15	-8.56	-24.07
Income Tax Expense	-0.14	-8.12	-	-	-
Earnings From Continuing Operations	-1.41	3.32	-8.15	-8.56	-24.07
Earnings From Discontinued Operations	-	-	-	-0.65	-0.31
Net Income	-1.41	3.32	-8.15	-9.21	-24.38
Net Income to Common	-1.41	3.32	-8.15	-9.21	-24.38
Shares Outstanding (Basic)	305	302	300	250	236
Shares Outstanding (Diluted)	305	302	300	250	236
Shares Change (YoY)	0.93%	0.89%	19.91%	5.90%	42.33%
EPS (Basic)	-0.00	0.01	-0.03	-0.04	-0.10
EPS (Diluted)	-0.00	0.01	-0.03	-0.04	-0.10
Free Cash Flow	-0.79	-1.15	-0.65	-8.76	-33.07
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.04	-0.14
Gross Margin	71.05%	67.70%	77.07%	69.50%	52.38%
Operating Margin	5.00%	-9.59%	-27.48%	-36.17%	-159.33%
Profit Margin	-3.32%	9.02%	-30.06%	-46.35%	-173.66%
Free Cash Flow Margin	-1.86%	-3.13%	-2.39%	-44.10%	-235.51%
EBITDA	5.44	-0.28	-4.57	-4.35	-21.06
EBITDA Margin	12.81%	-0.76%	-16.87%	-21.90%	-150.01%
D&A For EBITDA	3.31	3.25	2.88	2.83	1.31
EBIT	2.12	-3.53	-7.45	-7.18	-22.37
EBIT Margin	5.00%	-9.59%	-27.48%	-36.17%	-159.33%
Revenue as Reported	-	-	-	-	14.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.